Our model not only reflects the key role of CA125 for diagnosing ovarian cancer, but also suggests that the occurrence and development of ovarian cancer may be accompanied by the remodeling of cellular lipid metabolism and the complex interaction between the tumor and their hosts’ immune system [41,42,43,44]. This evidence concerns the gene MUC16 and ovarian cancer.